Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02437279 |
|---|---|
| Brief Title: | Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients (OpACIN) |
| First Submitted : | April 13, 2015 |
| First Submitted that Met QC Criteria : | May 4, 2015 |
| First Posted : | May 7, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 15, 2020 |
| Last Update Posted : | October 19, 2020 |